1. Early Treatment Innovation for Opioid-Dependent Newborns: A Retrospective Comparison of Outcomes, Utilization, Quality, and Safety, 2006–2014 
Julie Summey, EdD, Liwei Chen, MD, PhD, MHS, Rachel Mayo, PhD, Elizabeth Charron, MPH, Jennifer A. Hudson, MD, Windsor Westbrook Sherrill, PhD, MBA, MHA, Lori Dickes, PhD, MAAE 
Joint Commission Journal on Quality and Patient Safety 
Volume 44, Issue 6, Pages (June 2018)
DOI: /j.jcjq
Copyright © 2018 The Joint Commission Terms and Conditions

2. Figure 1
State records were available for 110 infants treated with the MAiN model. Among 2,496 neonatal abstinence syndrome (NAS) infants identified in South Carolina during the study period, 356 were used as the comparison group (traditional care NAS). ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification.
Joint Commission Journal on Quality and Patient Safety  , DOI: ( /j.jcjq )
Copyright © 2018 The Joint Commission Terms and Conditions

3. Figure 2
The number of state neonatal abstinence syndrome infants identified as MAiN eligible increased dramatically during the study period.
Joint Commission Journal on Quality and Patient Safety  , DOI: ( /j.jcjq )
Copyright © 2018 The Joint Commission Terms and Conditions

4. Figure 3
The emergency services utilization and inpatient readmissions results are presented. In the MAiN group, there were 31 emergency department (ED) visits and 13 inpatient readmissions. In the state traditional care neonatal abstinence syndrome (NAS) group, there were 67 ED visits and 44 inpatient readmissions.
Joint Commission Journal on Quality and Patient Safety  , DOI: ( /j.jcjq )
Copyright © 2018 The Joint Commission Terms and Conditions